Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

749
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
749
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

516
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
516

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Variability in epilepsy polygenic risk prediction across Taiwanese population and clinical cohorts.

Epilepsia·2026
Same author

Effectiveness of preoperative pulmonary rehabilitation in patients with lung cancer combined with moderate to severe COPD: study protocol for a randomized controlled trial.

Respiratory medicine·2026
Same author

Clinical spectrum of pediatric-onset Erdheim-Chester disease: insights from a single-center case series.

Frontiers in pediatrics·2026
Same author

Therapeutic effects of 40 Hz light stimulation on clinical and pathological features of Alzheimer's disease.

Dialogues in clinical neuroscience·2026
Same author

Development and Validation of a Machine Learning-Based Dementia Screening Tool: The Six-Question Dementia Screening Test.

American journal of Alzheimer's disease and other dementias·2026
Same author

Using Plasma Amyloid Beta Oligomer to Screen in Alzheimer's Disease: A Pilot Study.

International journal of molecular sciences·2026
Same journal

Patient-derived forebrain cortical organoids reveal biphasic tau-MAP6-microtubule axis dysfunction in tauopathy.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Genetic architecture of the limbic white matter microstructure in aging and Alzheimer's Disease.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Greater choroid plexus volume is linked to poor sleep, neurodegeneration, and cognitive deficits in older adults: Evidence from the IGNITE Study.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Plasma-based neurobiological protein biomarkers as predictors of dementia progression: Insights from longitudinal aging study in India - Diagnostic assessment of dementia.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Neuropathology-specific language features in primary progressive aphasia.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Dementia blood biomarkers in the context of post-stroke cognitive outcomes: Systematic review and evidence synthesis.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
查看所有相关文章

相关实验视频

Updated: Jan 7, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.1K

生物标志物 生物标志物

Pin-Chieh Hsu1, Jia-Ying Yang2, Yuan-Han Yang3,4,5,6

  • 1Kaohsiung Medical University, Kaohsiung, Kaohsiung, Taiwan.

Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 24, 2025
PubMed
概括
此摘要是机器生成的。

较高水平的粉样β oligomers (AβO) 与阿尔茨海默病 (AD) 有显著的联系. 这一发现表明AβO可以作为AD查的潜在血液生物标志物.

更多相关视频

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.9K
Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans
08:14

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

702

相关实验视频

Last Updated: Jan 7, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.1K
Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.9K
Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans
08:14

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

702

科学领域:

  • 神经科学是一个神经科学.
  • 生物标志物发现发现
  • 阿尔茨海默氏症疾病研究研究

背景情况:

  • 血氨基酸β oligomers (AβO),氨基酸β的有毒形式,与阿尔茨海默病 (AD) 的发展和进展有关.
  • 以前的研究表明,AβO在阿尔茨海默病的发病过程中起着关键作用.

研究的目的:

  • 与认知正常的对照组相比,对患有阿尔茨海默病 (AD) 个体的血粉样蛋白β oligomers (AβO) 和相关生物标志物进行研究.
  • 为了澄清血AβO水平和AD诊断之间的关联.

主要方法:

  • 一项涉及16名AD患者和16名认知正常对照 (NC) 的病例对照研究.
  • 使用ELISA套件测量了包括Aβ寡合体 (AβO),Aβ1-40和Aβ1-42在内的血生物标志物.
  • 分析了人口统计和临床数据 (年龄,性别,教育,APOE ε4,CDR,MMSE);使用斯皮尔曼相关性来评估关系.

主要成果:

  • 与NCs相比,在AD患者中观察到Aβ1-40,Aβ1-42和AβO的平均血度显著更高.
  • 血Aβ1-40 (67.4 pg/mL对比21.4 pg/mL,p < 0.001) 和AβO (157.1 pg/mL对比107.3 pg/mL,p = 0.003) 在AD中显著升高.
  • Aβ1-40和Aβ1-42/1-40比率与AβO水平显著相关 (分别为p=0.003和p=0.002).

结论:

  • 粉样β oligomers (AβO) 的血度升高与阿尔茨海默病 (AD) 有显著的关联.
  • 血AβO显示出作为阿尔茨海默病查生物标志物的潜力.
  • 需要对更大的队列进行进一步的研究来证实这些发现,并探索AβO的诊断实用性.